IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Column Group LLC

Q2 2023 Holdings

Filed 2023-07-24 | 7 holdings | $257.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$68.9M2,577,22026.8%
Tenaya Therapeutics, Inc.(TNYA)COM87990A106$55.2M9,400,29021.4%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$50.1M2,680,62119.5%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$47.0M18,136,73518.2%
Oric Pharmaceuticals Inc.(ORIC)COM68622P109$27.7M3,568,18110.7%
Surrozen, Inc.COM86889P109$5.2M9,414,7952.0%
eFFECTOR Therapeutics IncCOM28202V108$3.6M4,309,3291.4%